By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Orthofix Medical Inc.

Orthofix Medical Inc. (OFIX)

NASDAQ Currency in USD
$90.00
+$1.49
+1.68%
Last Update: 18 Jul 2026, 20:53
$3.59bn
Market Cap
-59.78
P/E Ratio (TTM)
Forward Dividend Yield
$60.19-$115.28
52 Week Range

OFIX Stock Price Chart

Explore Orthofix Medical Inc. interactive price chart. Choose custom timeframes to analyze OFIX price movements and trends.

OFIX Company Profile

Discover essential business fundamentals and corporate details for Orthofix Medical Inc. (OFIX) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

24 Apr 1992

Employees

1.62k

CEO

Massimo Calafiore

Description

Orthofix Medical Inc., founded in 1980 and headquartered in Lewisville, Texas, operates as a global medical technology company focusing on devices and biologics. Its reach extends across the United States, several European nations including Italy, Germany, France, and the United Kingdom, as well as Brazil and other international markets. The company's operations are divided into two main segments: Global Spine and Global Orthopedics. Within the Global Spine division, Orthofix is responsible for the development, production, and distribution of bone growth stimulators. These devices are designed to facilitate bone fusion and serve as a therapeutic intervention for fractures located outside the spine and in the limbs. This segment also creates and commercializes a range of motion preservation and fixation implant products utilized in spinal surgical procedures. Furthermore, it supplies physicians with various tissue forms and synthetic-based regenerative biologic solutions to address a wide spectrum of spinal and orthopedic conditions. The Global Orthopedics segment concentrates on the design, development, and commercialization of specialized orthopedic products. These offerings are essential for procedures involving fracture repair, the correction of deformities, and bone reconstruction. Orthofix distributes its products to a diverse clientele, including physicians, hospitals, outpatient surgery centers, and integrated health delivery systems. This is achieved through a comprehensive sales network that includes its own sales force, independent distributors, and both employed and external sales representatives. The company, previously known as Orthofix International N.V., officially changed its name to Orthofix Medical Inc. in July 2018.

OFIX Financial Timeline

Browse a chronological timeline of Orthofix Medical Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 5 Aug 2026

EPS estimate is -$0.41, while revenue estimate is $209.28m.

Earnings released on 5 May 2026

EPS came in at -$0.52 surpassing the estimated -$0.68 by +23.53%, while revenue for the quarter reached $196.71m , beating expectations by +0.16%.

Earnings released on 24 Feb 2026

EPS came in at -$0.06 surpassing the estimated -$0.19 by +70.79%, while revenue for the quarter reached $219.91m , beating expectations by +0.56%.

Earnings released on 4 Nov 2025

EPS came in at $0.20 surpassing the estimated $0.12 by +66.67%, while revenue for the quarter reached $205.63m , beating expectations by +2.82%.

Earnings released on 5 Aug 2025

EPS came in at $0.13 surpassing the estimated $0.04 by +225.00%, while revenue for the quarter reached $203.12m , beating expectations by +0.98%.

Earnings released on 6 May 2025

EPS came in at -$0.08 surpassing the estimated -$0.17 by +52.94%, while revenue for the quarter reached $193.65m , missing expectations by -5.19%.

Earnings released on 25 Feb 2025

EPS came in at $0.02 falling short of the estimated $0.06 by -66.67%, while revenue for the quarter reached $215.66m , beating expectations by +7.99%.

Earnings released on 7 Nov 2024

EPS came in at $0.07 surpassing the estimated -$0.14 by +150.00%, while revenue for the quarter reached $196.61m , missing expectations by -7.62%.

Earnings released on 6 Aug 2024

EPS came in at $0.05 surpassing the estimated -$0.13 by +138.46%, while revenue for the quarter reached $198.62m , beating expectations by +1.74%.

Earnings released on 7 May 2024

EPS came in at -$0.46 falling short of the estimated -$0.32 by -43.75%, while revenue for the quarter reached $188.61m , beating expectations by +2.43%.

Earnings released on 5 Mar 2024

EPS came in at -$0.10 surpassing the estimated -$0.14 by +28.57%, while revenue for the quarter reached $200.42m , beating expectations by +2.61%.

Earnings released on 8 Nov 2023

EPS came in at $0.07 surpassing the estimated -$0.22 by +131.82%, while revenue for the quarter reached $184.01m , missing expectations by -5.85%.

Earnings released on 8 Aug 2023

EPS came in at $0.02 surpassing the estimated -$0.67 by +102.99%, while revenue for the quarter reached $187.02m , beating expectations by +0.75%.

Earnings released on 9 May 2023

EPS came in at -$0.10 surpassing the estimated -$0.20 by +50.00%, while revenue for the quarter reached $175.20m , beating expectations by +4.02%.

Earnings released on 6 Mar 2023

EPS came in at $0.19 surpassing the estimated -$0.37 by +151.35%, while revenue for the quarter reached $122.23m , missing expectations by -15.68%.

Earnings released on 3 Nov 2022

EPS came in at $0.13 surpassing the estimated $0.12 by +11.40%, while revenue for the quarter reached $114.00m , missing expectations by 0.00%.

Earnings released on 5 Aug 2022

EPS came in at $0.08 surpassing the estimated $0.07 by +14.29%, while revenue for the quarter reached $118.07m , missing expectations by -0.15%.

Earnings released on 6 May 2022

EPS came in at -$0.10 falling short of the estimated $0.09 by -211.11%, while revenue for the quarter reached $106.42m , beating expectations by +1.98%.

Earnings released on 25 Feb 2022

EPS came in at $0.27 surpassing the estimated $0.13 by +107.69%, while revenue for the quarter reached $125.06m , beating expectations by +0.05%.

Earnings released on 5 Nov 2021

EPS came in at $0.10 falling short of the estimated $0.13 by -23.08%, while revenue for the quarter reached $112.43m , missing expectations by -8.18%.

Earnings released on 6 Aug 2021

EPS came in at $0.32 surpassing the estimated $0.16 by +100.00%, while revenue for the quarter reached $121.39m , beating expectations by +12.19%.

OFIX Stock Performance

Access detailed OFIX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run